KR100511222B1 - 동아 추출물을 함유하는 여드름 피부용 화장료 조성물과그의 제조방법 - Google Patents
동아 추출물을 함유하는 여드름 피부용 화장료 조성물과그의 제조방법Info
- Publication number
- KR100511222B1 KR100511222B1 KR10-2002-0031624A KR20020031624A KR100511222B1 KR 100511222 B1 KR100511222 B1 KR 100511222B1 KR 20020031624 A KR20020031624 A KR 20020031624A KR 100511222 B1 KR100511222 B1 KR 100511222B1
- Authority
- KR
- South Korea
- Prior art keywords
- dong
- acne
- extract
- cosmetic composition
- hydrous
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 208000002874 Acne Vulgaris Diseases 0.000 title claims abstract description 55
- 206010000496 acne Diseases 0.000 title claims abstract description 55
- 239000000284 extract Substances 0.000 title claims abstract description 53
- 239000002537 cosmetic Substances 0.000 title claims abstract description 28
- 230000002401 inhibitory effect Effects 0.000 title claims abstract description 9
- 238000000034 method Methods 0.000 title claims description 13
- 239000000203 mixture Substances 0.000 claims abstract description 62
- 229940055019 propionibacterium acne Drugs 0.000 claims abstract description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 27
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 20
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 16
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 15
- 239000002904 solvent Substances 0.000 claims description 15
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 9
- 235000011187 glycerol Nutrition 0.000 claims description 8
- 239000006071 cream Substances 0.000 claims description 7
- 238000000605 extraction Methods 0.000 claims description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 6
- 239000004480 active ingredient Substances 0.000 claims description 5
- 239000006210 lotion Substances 0.000 claims description 4
- 235000013399 edible fruits Nutrition 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 2
- 239000000344 soap Substances 0.000 claims description 2
- 238000011282 treatment Methods 0.000 abstract description 15
- 241000186427 Cutibacterium acnes Species 0.000 abstract description 5
- 230000000069 prophylactic effect Effects 0.000 abstract description 2
- 208000024891 symptom Diseases 0.000 abstract description 2
- 238000009472 formulation Methods 0.000 description 26
- 230000000694 effects Effects 0.000 description 16
- 241000894006 Bacteria Species 0.000 description 14
- 230000000052 comparative effect Effects 0.000 description 14
- 238000004519 manufacturing process Methods 0.000 description 13
- 210000003491 skin Anatomy 0.000 description 13
- 238000003756 stirring Methods 0.000 description 12
- 235000016709 nutrition Nutrition 0.000 description 9
- 239000003995 emulsifying agent Substances 0.000 description 7
- 238000001816 cooling Methods 0.000 description 6
- 238000004945 emulsification Methods 0.000 description 6
- 239000008213 purified water Substances 0.000 description 6
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 6
- 230000002421 anti-septic effect Effects 0.000 description 5
- 230000018109 developmental process Effects 0.000 description 5
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 230000035764 nutrition Effects 0.000 description 5
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 5
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 239000000686 essence Substances 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 239000000049 pigment Substances 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 239000008279 sol Substances 0.000 description 4
- 235000013599 spices Nutrition 0.000 description 4
- 239000004342 Benzoyl peroxide Substances 0.000 description 3
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 206010040880 Skin irritation Diseases 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 235000021355 Stearic acid Nutrition 0.000 description 3
- 239000004098 Tetracycline Substances 0.000 description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 3
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 3
- 235000013871 bee wax Nutrition 0.000 description 3
- 239000012166 beeswax Substances 0.000 description 3
- 235000019400 benzoyl peroxide Nutrition 0.000 description 3
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 3
- 229940057995 liquid paraffin Drugs 0.000 description 3
- 150000007523 nucleic acids Chemical class 0.000 description 3
- 102000039446 nucleic acids Human genes 0.000 description 3
- 108020004707 nucleic acids Proteins 0.000 description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
- CKQVRZJOMJRTOY-UHFFFAOYSA-N octadecanoic acid;propane-1,2,3-triol Chemical compound OCC(O)CO.CCCCCCCCCCCCCCCCCC(O)=O CKQVRZJOMJRTOY-UHFFFAOYSA-N 0.000 description 3
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 229930002330 retinoic acid Natural products 0.000 description 3
- 229960004889 salicylic acid Drugs 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 230000036556 skin irritation Effects 0.000 description 3
- 231100000475 skin irritation Toxicity 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000008117 stearic acid Substances 0.000 description 3
- 229940111630 tea tree oil Drugs 0.000 description 3
- 239000010677 tea tree oil Substances 0.000 description 3
- 229960002180 tetracycline Drugs 0.000 description 3
- 229930101283 tetracycline Natural products 0.000 description 3
- 235000019364 tetracycline Nutrition 0.000 description 3
- 150000003522 tetracyclines Chemical class 0.000 description 3
- 229960001727 tretinoin Drugs 0.000 description 3
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- 244000036905 Benincasa cerifera Species 0.000 description 2
- 235000011274 Benincasa cerifera Nutrition 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 235000019493 Macadamia oil Nutrition 0.000 description 2
- 235000002789 Panax ginseng Nutrition 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 2
- 150000004347 all-trans-retinol derivatives Chemical class 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000002280 anti-androgenic effect Effects 0.000 description 2
- 239000000051 antiandrogen Substances 0.000 description 2
- 229940030495 antiandrogen sex hormone and modulator of the genital system Drugs 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 229960003276 erythromycin Drugs 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 235000015203 fruit juice Nutrition 0.000 description 2
- 229940075529 glyceryl stearate Drugs 0.000 description 2
- 230000009036 growth inhibition Effects 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 239000010469 macadamia oil Substances 0.000 description 2
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 2
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 2
- 229940113124 polysorbate 60 Drugs 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 2
- 210000002374 sebum Anatomy 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 2
- 229950011392 sorbitan stearate Drugs 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 240000001980 Cucurbita pepo Species 0.000 description 1
- 235000009852 Cucurbita pepo Nutrition 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 240000001417 Vigna umbellata Species 0.000 description 1
- 235000011453 Vigna umbellata Nutrition 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229940009868 aluminum magnesium silicate Drugs 0.000 description 1
- WMGSQTMJHBYJMQ-UHFFFAOYSA-N aluminum;magnesium;silicate Chemical compound [Mg+2].[Al+3].[O-][Si]([O-])([O-])[O-] WMGSQTMJHBYJMQ-UHFFFAOYSA-N 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 230000003255 anti-acne Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229960003328 benzoyl peroxide Drugs 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- 235000021438 curry Nutrition 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- RNPXCFINMKSQPQ-UHFFFAOYSA-N dicetyl hydrogen phosphate Chemical compound CCCCCCCCCCCCCCCCOP(O)(=O)OCCCCCCCCCCCCCCCC RNPXCFINMKSQPQ-UHFFFAOYSA-N 0.000 description 1
- 229940093541 dicetylphosphate Drugs 0.000 description 1
- 231100000676 disease causative agent Toxicity 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 229940125697 hormonal agent Drugs 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- 208000017983 photosensitivity disease Diseases 0.000 description 1
- 231100000434 photosensitization Toxicity 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- -1 retinoic acid Chemical class 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 244000005714 skin microbiome Species 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 235000001508 sulfur Nutrition 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001364 upper extremity Anatomy 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 239000004034 viscosity adjusting agent Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B31—MAKING ARTICLES OF PAPER, CARDBOARD OR MATERIAL WORKED IN A MANNER ANALOGOUS TO PAPER; WORKING PAPER, CARDBOARD OR MATERIAL WORKED IN A MANNER ANALOGOUS TO PAPER
- B31F—MECHANICAL WORKING OR DEFORMATION OF PAPER, CARDBOARD OR MATERIAL WORKED IN A MANNER ANALOGOUS TO PAPER
- B31F1/00—Mechanical deformation without removing material, e.g. in combination with laminating
- B31F1/0003—Shaping by bending, folding, twisting, straightening, flattening or rim-rolling; Shaping by bending, folding or rim-rolling combined with joining; Apparatus therefor
- B31F1/0006—Bending or folding; Folding edges combined with joining; Reinforcing edges during the folding thereof
- B31F1/0009—Bending or folding; Folding edges combined with joining; Reinforcing edges during the folding thereof of plates, sheets or webs
- B31F1/0019—Bending or folding; Folding edges combined with joining; Reinforcing edges during the folding thereof of plates, sheets or webs the plates, sheets or webs moving continuously
- B31F1/0022—Bending or folding; Folding edges combined with joining; Reinforcing edges during the folding thereof of plates, sheets or webs the plates, sheets or webs moving continuously combined with making folding lines
- B31F1/0025—Making the folding lines using rotary tools
Landscapes
- Engineering & Computer Science (AREA)
- Mechanical Engineering (AREA)
- Cosmetics (AREA)
Abstract
Description
용매 | 온도 | 수득량 [kg] | |
실시예 2 | 50% 함수 에탄올 | 70℃ | 4.8 |
실시예 3 | 에틸아세테이트 | 70℃ | 4.6 |
실시예 4 | 핵산 | 70℃ | 4.6 |
실시예 5 | 물 | 70℃ | 4.6 |
실시예 6 | 부틸렌 글리콜 | 80℃ | 4.6 |
실시예 7 | 50% 함수 부틸렌글리콜 | 80℃ | 4.6 |
실시예 8 | 글리세린 | 80℃ | 4.6 |
실시예 9 | 에틸렌 글리콜 | 80℃ | 4.7 |
실시예 10 | 프로필렌 글리콜 | 80℃ | 4.8 |
용매 | 수득량 [g] | |
실시예 12 | 50% 함수 에탄올 | 69 |
실시예 13 | 에틸아세테이트 | 41 |
실시예 14 | 핵산 | 38 |
실시예 15 | 물 | 76 |
용매 | 수득량 [kg] | |
실시예 17 | 50% 함수 에탄올 | 4.6 |
실시예 18 | 에틸아세테이트 | 4.5 |
실시예 19 | 핵산 | 4.3 |
실시예 20 | 물 | 4.7 |
실시예 21 | 부틸렌글리콜 | 4.6 |
실시예 22 | 50% 함수 부틸렌글리콜 | 4.7 |
실시예 23 | 글리세린 | 4.6 |
실시예 24 | 에틸렌 글리콜 | 4.6 |
실시예 25 | 프로필렌 글리콜 | 4.6 |
시 료 명 | 억제율(Φ,㎝) | |
1 | Tea tree oil(water soluble) | 4.8 |
2 | 실시예 6의 동아 추출물 | 3.6 |
3 | 실시예 11의 동아 추출물(5% Sol'n) | 3.5 |
4 | 실시예 21의 동아 추출물 | 3.2 |
5 | Salicylic acid(5% Sol'n) | 2.7 |
시 료 명 | 대조군의 여드름균 수(N1) | 실험액을 가한지 3일 후의 여드름균 수(N2) | 여드름균에대한 살균율 | |
1 | Tea tree oil(water soluble) | 870 | 60 | 93.1 |
2 | 실시예 6 | 870 | 67 | 92.3 |
3 | 실시예 11(5% Sol'n) | 870 | 65 | 92.5 |
4 | 실시예 21 | 870 | 62 | 92.9 |
5 | Salicylic acid(5% Sol'n) | 870 | 72 | 91.7 |
번 호 | 성 분 | 제형예 1 | 비교제형예 1 |
1 | 동아 추출물(실시예 21) | 5.0 | - |
2 | 밀납 | 1.0 | 1.0 |
3 | 폴리솔베이트 60 | 1.5 | 1.5 |
4 | 솔비탄세스퀴올레이트 | 0.5 | 0.5 |
5 | 유동파라핀 | 10.0 | 10.0 |
6 | 소르비탄 스테아레이트 | 1.0 | 1.0 |
7 | 친유형 모노스테아린산 글리세린 | 0.5 | 0.5 |
8 | 스테아린산 | 1.5 | 1.5 |
9 | 글리세릴스테아레이트/피이지-400 스테아레이트 | 1.0 | 1.0 |
10 | 프로필렌글리콜 | 3.0 | 3.0 |
11 | 카르복시비닐폴리머 | 0.1 | 0.1 |
12 | 트리에탄올아민 | 0.2 | 0.2 |
13 | 방부제 | 미량 | 미량 |
14 | 색소 | 미량 | 미량 |
15 | 향료 | 미량 | 미량 |
16 | 정제수 | 잔량 | 잔량 |
번 호 | 원 료 | 제형예 2 | 비교제형예 2 |
1 | 동아 추출물(실시예 21) | 5.0 | - |
2 | 밀납 | 8.0 | 8.0 |
3 | 폴리솔베이트 60 | 1.5 | 1.5 |
4 | 솔비탄세스퀴올레이트 | 0.5 | 0.5 |
5 | 유동파라핀 | 20.0 | 20.0 |
6 | 소르비탄 스테아레이트 | 1.0 | 1.0 |
7 | 친유형 모노 스테아린산 글리세린 | 0.5 | 0.5 |
8 | 스테아린산 | 1.5 | 1.5 |
9 | 글리세릴스테아레이트/피이지-400 스테아레이트 | 1.0 | 1.0 |
10 | 프로필렌글리콜 | 6.0 | 6.0 |
11 | 트리에탄올아민 | 0.2 | 0.2 |
12 | 방부제 | 미량 | 미량 |
13 | 색소 | 미량 | 미량 |
14 | 향료 | 미량 | 미량 |
15 | 정제수 | 잔량 | 잔량 |
번 호 | 원 료 | 제형예 3 | 비교제형예 3 |
1 | 동아 추출물(실시예 21) | 5.0 | - |
2 | 시토 스테롤 | 1.7 | 1.7 |
3 | 폴리 글리세릴 2-올레이트 | 1.5 | 1.5 |
4 | 세라마이드 | 0.7 | 0.7 |
5 | 세테아레스-4 | 1.2 | 1.2 |
6 | 콜레스테롤 | 1.5 | 1.5 |
7 | 디세틸포스페이트 | 0.4 | 0.4 |
8 | 농글리세린 | 5.0 | 5.0 |
9 | 마카데미아 오일 | 15.0 | 15.0 |
10 | 카르복시비닐폴리머 | 0.2 | 0.2 |
11 | 산탄검 | 0.2 | 0.2 |
12 | 방부제 | 미량 | 미량 |
13 | 향료 | 미량 | 미량 |
14 | 정제수 | 잔량 | 잔량 |
번 호 | 원 료 | 제형예 4 | 비교제형예 4 |
1 | 동아 추출물(실시예 21) | 5.0 | - |
2 | 밀납 | 2.0 | 2.0 |
3 | 사이크로메치콘 | 2.0 | 2.0 |
4 | 유동파라핀 | 5.0 | 5.0 |
5 | 스쿠알란 | 5.0 | 5.0 |
6 | 스테아린산 | 2.0 | 2.0 |
7 | 친유성 모노스테아린산 글리세린 | 3.0 | 3.0 |
8 | 마카데미아 오일 | 4.0 | 4.0 |
9 | 글리세린 | 4.0 | 4.0 |
10 | 프로필렌글리콜 | 3.0 | 3.0 |
11 | 부틸렌글리콜 | 3.0 | 3.0 |
12 | 트리에탄올아민 | 1.0 | 1.0 |
13 | 알루미늄마그네슘실리케이트 | 0.5 | 0.5 |
14 | 안료 | 12.0 | 12.0 |
15 | 방부제 | 미량 | 미량 |
16 | 향료 | 미량 | 미량 |
17 | 정제수 | 잔량 | 잔량 |
상당한 개선 | 약간 개선 | 효과 없음 | 악화 | |
제형예 2의 영양크림 | 6명 | 5명 | 2명 | 0명 |
비교제형예 2의 영양크림 | 0명 | 3명 | 4명 | 6명 |
제형예 3의 영양에센스 | 8명 | 3명 | 2명 | 0명 |
비교제형예 3의 영양에센스 | 0명 | 4명 | 6명 | 3명 |
Claims (5)
- 유효성분으로 동아추출물을 함유하여 상기 동아추출물에 의한 프로피오니박테리움 아크네의 생육억제에 의하여 여드름을 억제하는 화장료 조성물로서,상기 동아추출물은 동아열매에서 씨를 제거한 후 1~20배의 추출용매를 가하여 50~95℃ 온도에서 가열하거나 1~15일간 침적시켜 추출한 것임을 특징으로 하는 여드름피부용 화장료 조성물.
- 삭제
- 제 1항에 있어서, 상기 추출용매는 물, 에탄올, 에틸아세테이트, 헥산, 글리세린, 에틸렌글리콜, 부틸렌글리콜, 프로필렌글리콜, 함수 에탄올, 함수 글리세린, 함수 에틸렌글리콜, 함수 부틸렌글리콜 및 함수 프로필렌글리콜로 이루어진 군에서 선택된 1종 또는 2종이상의 용매인 것을 특징으로 하는 여드름 피부용 화장료 조성물.
- 제 1항에 있어서, 상기 동아 추출물은 조성물 총 중량에 대하여 0.001~20중량%의 양으로 함유함을 특징으로 하는 여드름 피부용 화장료.
- 제 1항, 제 3항 또는 제 4항에 있어서, 여드름 피부용 화장료는 영양크림, 영양로션, 맛사지크림, 영양에센스, 유연화장수, 팩, 유화형파운데이션, 비누, 세안품과 같은 세안료 화장수임을 특징으로 하는 여드름 피부용 화장료 조성물.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2002-0031624A KR100511222B1 (ko) | 2002-06-05 | 2002-06-05 | 동아 추출물을 함유하는 여드름 피부용 화장료 조성물과그의 제조방법 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2002-0031624A KR100511222B1 (ko) | 2002-06-05 | 2002-06-05 | 동아 추출물을 함유하는 여드름 피부용 화장료 조성물과그의 제조방법 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20030093778A KR20030093778A (ko) | 2003-12-11 |
KR100511222B1 true KR100511222B1 (ko) | 2005-08-31 |
Family
ID=32386028
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR10-2002-0031624A Expired - Lifetime KR100511222B1 (ko) | 2002-06-05 | 2002-06-05 | 동아 추출물을 함유하는 여드름 피부용 화장료 조성물과그의 제조방법 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100511222B1 (ko) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008037764A (ja) * | 2006-08-02 | 2008-02-21 | Shiseido Co Ltd | 皮脂分泌抑制剤およびニキビ改善用皮膚外用剤 |
KR100985229B1 (ko) * | 2009-11-30 | 2010-10-05 | 광주광역시 남구 | 동아를 이용한 세정 조성물 및 이의 제조방법 |
WO2019088643A2 (ko) * | 2017-10-31 | 2019-05-09 | 주식회사 케이바이오랩 | 생약 추출물을 유효성분으로 포함하는 미생물 균총 개선용 조성물 |
KR102001238B1 (ko) * | 2017-10-31 | 2019-07-18 | 주식회사 케이바이오랩 | 동과자 추출물을 유효성분으로 포함하는 미생물 균총 개선용 조성물 |
FR3094878A1 (fr) * | 2019-04-11 | 2020-10-16 | Qiaosheng Li | Masque facial pour eliminer l’acné |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0648934A (ja) * | 1992-06-02 | 1994-02-22 | Sansho Seiyaku Co Ltd | 皮膚外用剤 |
JPH0899891A (ja) * | 1994-01-21 | 1996-04-16 | Pola Chem Ind Inc | 皮膚外用剤 |
US5547673A (en) * | 1992-12-09 | 1996-08-20 | Indena S.P.A. | Extracts of cucurbita sp., process for their preparation and their use in medicaments and in cosmetics |
JP2001226249A (ja) * | 2000-02-17 | 2001-08-21 | Ichimaru Pharcos Co Ltd | 植物水蒸気蒸留水含有化粧料組成物 |
-
2002
- 2002-06-05 KR KR10-2002-0031624A patent/KR100511222B1/ko not_active Expired - Lifetime
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0648934A (ja) * | 1992-06-02 | 1994-02-22 | Sansho Seiyaku Co Ltd | 皮膚外用剤 |
US5547673A (en) * | 1992-12-09 | 1996-08-20 | Indena S.P.A. | Extracts of cucurbita sp., process for their preparation and their use in medicaments and in cosmetics |
JPH0899891A (ja) * | 1994-01-21 | 1996-04-16 | Pola Chem Ind Inc | 皮膚外用剤 |
JP2001226249A (ja) * | 2000-02-17 | 2001-08-21 | Ichimaru Pharcos Co Ltd | 植物水蒸気蒸留水含有化粧料組成物 |
Also Published As
Publication number | Publication date |
---|---|
KR20030093778A (ko) | 2003-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3635081B2 (ja) | 美白剤、抗酸化剤、コラゲナーゼ活性阻害剤、ヒアルロニダーゼ活性阻害剤、老化防止剤、皮膚外用剤、化粧料及び食料品 | |
KR20200114810A (ko) | 무화과잎 주정 추출물을 포함하는 화장료 조성물의 제조방법 | |
KR102400179B1 (ko) | 인진쑥 추출물 및 올리브 추출물을 유효성분으로 포함하는 항균, 항산화, 미백 및 항염증용 화장료 조성물 | |
KR101921086B1 (ko) | 수소수 및 카무카무 추출물을 유효성분으로 함유하는 혈행촉진 및 피부톤 개선용 화장료 조성물 | |
JPH023495A (ja) | 抗酸化剤 | |
KR100511222B1 (ko) | 동아 추출물을 함유하는 여드름 피부용 화장료 조성물과그의 제조방법 | |
KR20140145278A (ko) | 피부 수렴 및 탄력 효과를 갖는 승마 추출물, 산수유 추출물 및 현초 추출물을 함유하는 화장료 조성물. | |
KR100350083B1 (ko) | 미백 화장료 조성물 | |
KR101985381B1 (ko) | 포도, 오렌지, 사과, 레몬 및 라임을 발효하여 만든 과일 발효액 콤플렉스를 함유하는 피부 각질 박리용 화장료 조성물 | |
KR101425757B1 (ko) | 여드름 개선용 피부 마사지 조성물 및 이를 포함하는 마스크팩 | |
KR101797526B1 (ko) | 황칠나무 발효추출물을 함유한 모발용 화장료 조성물 | |
KR101679480B1 (ko) | 천연 추출물을 함유하는 여드름 개선용 화장료 조성물 | |
JPH01102011A (ja) | 皮膚化粧料 | |
KR100471986B1 (ko) | 여드름 방지용 화장료 조성물 | |
KR102331207B1 (ko) | 발효복분자추출물을 포함하는 항산화 조성물 | |
KR102294278B1 (ko) | 발효오디추출물을 포함하는 항산화 조성물 | |
KR102154139B1 (ko) | 고로쇠나무 수액의 발효액, 카카오닙스 추출물 및 석류피 추출물을 포함하는 조성물 | |
KR101138157B1 (ko) | 천연비누 및 그 제조방법 | |
KR20220140307A (ko) | 담팔수 추출물 또는 이의 분획물을 유효성분으로 함유하는 항산화용 조성물 | |
KR20020001931A (ko) | 황백 추출물 및/또는 오미자 추출물을 함유하는 여드름억제 화장료 | |
KR100909729B1 (ko) | 남실 추출물을 함유한 여드름 예방 및 개선용 화장료 조성물 | |
KR20200069778A (ko) | 발효복분자추출물을 포함하는 항산화 조성물 | |
KR20210065591A (ko) | 부아메라열매오일과 클로브꽃추출물을 유효성분으로 포함하는 기능성 화장료 조성물 | |
KR100441131B1 (ko) | 천연 향유를 함유하는 여드름 화장료 조성물 | |
KR102465347B1 (ko) | 구절초 잎줄기 열수 추출물을 유효성분으로 포함하는 항염증 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20020605 |
|
PA0201 | Request for examination | ||
N231 | Notification of change of applicant | ||
PN2301 | Change of applicant |
Patent event date: 20020926 Comment text: Notification of Change of Applicant Patent event code: PN23011R01D |
|
PG1501 | Laying open of application | ||
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20040831 Patent event code: PE09021S01D |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20050523 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20050823 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20050824 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
PR1001 | Payment of annual fee |
Payment date: 20080801 Start annual number: 4 End annual number: 4 |
|
PR1001 | Payment of annual fee |
Payment date: 20090605 Start annual number: 5 End annual number: 5 |
|
PR1001 | Payment of annual fee |
Payment date: 20100813 Start annual number: 6 End annual number: 6 |
|
PR1001 | Payment of annual fee |
Payment date: 20111101 Start annual number: 7 End annual number: 7 |
|
PR1001 | Payment of annual fee |
Payment date: 20120529 Start annual number: 8 End annual number: 8 |
|
FPAY | Annual fee payment |
Payment date: 20130529 Year of fee payment: 9 |
|
PR1001 | Payment of annual fee |
Payment date: 20130529 Start annual number: 9 End annual number: 9 |
|
FPAY | Annual fee payment |
Payment date: 20140529 Year of fee payment: 10 |
|
PR1001 | Payment of annual fee |
Payment date: 20140529 Start annual number: 10 End annual number: 10 |
|
FPAY | Annual fee payment |
Payment date: 20150821 Year of fee payment: 11 |
|
PR1001 | Payment of annual fee |
Payment date: 20150821 Start annual number: 11 End annual number: 11 |
|
FPAY | Annual fee payment |
Payment date: 20160823 Year of fee payment: 12 |
|
PR1001 | Payment of annual fee |
Payment date: 20160823 Start annual number: 12 End annual number: 12 |
|
FPAY | Annual fee payment |
Payment date: 20170823 Year of fee payment: 13 |
|
PR1001 | Payment of annual fee |
Payment date: 20170823 Start annual number: 13 End annual number: 13 |
|
FPAY | Annual fee payment |
Payment date: 20180823 Year of fee payment: 14 |
|
PR1001 | Payment of annual fee |
Payment date: 20180823 Start annual number: 14 End annual number: 14 |
|
FPAY | Annual fee payment |
Payment date: 20190822 Year of fee payment: 15 |
|
PR1001 | Payment of annual fee |
Payment date: 20190822 Start annual number: 15 End annual number: 15 |
|
PR1001 | Payment of annual fee |
Payment date: 20200824 Start annual number: 16 End annual number: 16 |
|
PR1001 | Payment of annual fee |
Payment date: 20210823 Start annual number: 17 End annual number: 17 |
|
PC1801 | Expiration of term |
Termination date: 20221205 Termination category: Expiration of duration |